These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 13678005)

  • 1. [Effects of complex therapy with emoxipin on the course of diabetic retinopathy].
    Kozlov SA; Khyshiktuev BS; Logunov NA
    Vestn Oftalmol; 2003; 119(2):28-30. PubMed ID: 13678005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid peroxidation and antioxidant status in patients with diabetic retinopathy.
    Gupta MM; Chari S
    Indian J Physiol Pharmacol; 2005 Apr; 49(2):187-92. PubMed ID: 16170987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Coagulation activity of the lacrimal fluid and the concentration of glucose in it as a criterion of diagnosis and prognosis of early-stage diabetic retinopathy].
    Gavrilova NA; Shpak AA; Rudneva MA; Pankova OP; Lanevskaia NI
    Vestn Oftalmol; 2003; 119(6):27-9. PubMed ID: 14708170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of emoxipine, reamberine and mexidol on neuropathic symptoms and a systolic function of the left ventricular myocardium in patients with diabetes mellitus and diabetic foot syndrome].
    Volchegorskiĭ IA; Moskvicheva MG; Chashchina EN
    Ter Arkh; 2005; 77(10):10-5. PubMed ID: 16320677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for eye complications in patients with diabetes mellitus: development and progression.
    el-Shazly M; Zeid M; Osman A
    East Mediterr Health J; 2000; 6(2-3):313-25. PubMed ID: 11556018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal Cambridge low-contrast grating sensitivity results associated with diabetic retinopathy as a potential screening tool.
    Abrishami M; Heravian J; Derakhshan A; Mousavi M; Banaee T; Daneshvar R; Moghaddam HO
    East Mediterr Health J; 2007; 13(4):810-8. PubMed ID: 17955763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of using emoxipine in true eczema].
    Grikurov KG; Fedorov SM
    Vestn Dermatol Venerol; 1990; (4):67-9. PubMed ID: 2389614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The efficacy of emoxipin and neoton in unstable stenocardia].
    Golikov AP; Riabinin VA; Golikov PP; Davydov BV; Polumiskov VIu; Rudnev DV; Taranova ZV
    Ter Arkh; 1996; 68(1):31-3. PubMed ID: 8644026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Emoxipine correction of lipid peroxidation disorders in patients with osteoarthrosis deformans].
    Shved NI; Belozetskaia-Smiian SI
    Vrach Delo; 1991 Oct; (10):101-3. PubMed ID: 1803728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The enzyme therapy within a complex treatment of hemophthalmos in patients with diabetes mellitus].
    Polunin GS; Andzhelova DV; Kiseleva TN
    Vestn Oftalmol; 2004; 120(5):14-6. PubMed ID: 15529531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ocular manifestations of diabetes: 285 cases].
    Zghal-Mokni I; Nacef L; Letaief I; Mahjoub S; Bouguila H; Blouza S; Jeddi A; Ayed S
    Tunis Med; 2008 Nov; 86(11):1004-7. PubMed ID: 19213494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative evaluation of the oxidant and antioxidant blood systems in rabbits with caustic burns of the eyes in their treatment by synthetic and natural antioxidants].
    Travkin AG; Shul'gina NA
    Vestn Oftalmol; 2004; 120(5):26-8. PubMed ID: 15529536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of antioxidant therapy for non-proliferative diabetic retinopathy in patients with type 2 diabetes mellitus].
    Alekseev IB; Vorob'eva IV; Mikhaleva LG; Gigineishvili DN; Merkushenkova DA
    Vestn Oftalmol; 2013; 129(6):66-71. PubMed ID: 24624806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Role of vascular endothelial growth factor in the development of diabetic retinopathy in patients with type 1 diabetes mellitus].
    Ermakova NA; Syrodeeva ON; Antsiferov MB; Balatskaia NV; Krasnova LB
    Vestn Oftalmol; 2008; 124(1):25-8. PubMed ID: 18318205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The results of research on the antioxidant emoksipin in clinical eye diseases].
    Egorov EA; Shvedova AA; Obraztsova IA
    Vestn Oftalmol; 1989; 105(5):52-5. PubMed ID: 2595902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic retinopathy. The diabetes eye exam initiative.
    Bhavsar AR
    Minn Med; 2002 Jun; 85(6):46-7. PubMed ID: 12092439
    [No Abstract]   [Full Text] [Related]  

  • 17. [Efficacy of emoxipin in treatment of arterial hypertension in the Far North].
    Vershinina AM; Gapon LI; Shurkevich NP; Bazhukhina IF; Petelina TI; Savel'eva NIu
    Klin Med (Mosk); 1999; 77(12):43-6. PubMed ID: 10684216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic significance of local and systemic indicators of lipid peroxidation and antioxidant system in perforating wounds of the eyes and their time course during local antioxidant treatment].
    Arkhipova LT; Dolgova IG
    Vestn Oftalmol; 2001; 117(5):37-40. PubMed ID: 11765467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the natural course of diabetic retinopathy: a population-based study in Kinmen, Taiwan.
    Tung TH; Chen SJ; Shih HC; Chou P; Li AF; Shyong MP; Lee FL; Liu JH
    Ophthalmic Epidemiol; 2006 Oct; 13(5):327-33. PubMed ID: 17060111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonproliferative retinopathy in diabetes type 2. Initial stages and characterization of phenotypes.
    Cunha-Vaz J; Bernardes R
    Prog Retin Eye Res; 2005 May; 24(3):355-77. PubMed ID: 15708833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.